Cytochrome P450 pathways of arachidonic acid metabolism

被引:162
作者
Kroetz, DL
Zeldin, DC
机构
[1] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA
[2] Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
D O I
10.1097/00041433-200206000-00007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450s metabolize arachidonic acid to hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. These eicosanoids are formed in a tissue and cell-specific manner and have numerous biological functions. Of major interest are the opposing actions of hydroxyeicosatetraenoic and epoxyeicosatrienoic acids within the vasculature. Regio- and stereoisomeric epoxyeicosatrienoic acids have potent vasodilatory proper-ties while 20-hydroxyeicosatetraenoic acid is a potent vasoconstrictor. Both effects are mediated through actions on large-conductance Ca2+-activated K+ channels. Cytochrome P450-derived eicosanoids are also important in the regulation of ion transport, and have recently been shown to influence a number of fundamental biological processes including cellular proliferation, apoptosis, inflammation, and hemostasis. The formation of these functionally relevant eicosanoids is tightly controlled by the expression and activity of the cytochrome P450 epoxygenases and hydroxylases. In addition, soluble epoxide hydrolase catalyzes the hydrolysis of epoxyeicosatrienoic acids to dihydroxyeicosatrienoic acids, and the activity of this enzyme is a critical determinant of tissue epoxyeicosatrienoic and dihydroxyeicosatrienoic acid levels. The intracellular balance between epoxyeicosatrienoic, dihydroxyeicosatrienoic and hydroxyeicosatetraenoic acids influences the biological response to these eicosanoids and alterations in their levels have recently been associated with certain pathological conditions. The involvement of the cytochrome P450-derived ecosanoids in a wide array of biological functions and the observation that levels are altered in pathological conditions suggest that the enzymes involved in the formation and degradation of these fatty acids may be novel therapeutic targets. Curr Opin Lipidol 13:273-283. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:273 / 283
页数:11
相关论文
共 120 条
[21]   Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid [J].
Dai, D ;
Zeldin, DC ;
Blaisdell, JA ;
Chanas, B ;
Coulter, SJ ;
Ghanayem, BI ;
Goldstein, JA .
PHARMACOGENETICS, 2001, 11 (07) :597-607
[22]   Role of gap junctions and EETs in endothelium-dependent hyperpolarization of porcine coronary artery [J].
Edwards, G ;
Thollon, C ;
Gardener, MJ ;
Félétou, M ;
Vilaine, JP ;
Vanhoutte, PM ;
Weston, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (06) :1145-1154
[23]  
Fang X, 2000, J LIPID RES, V41, P66
[24]   Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells - Implications for the vascular effects of soluble epoxide hydrolase inhibition [J].
Fang, X ;
Kaduce, TL ;
Weintraub, NL ;
Harmon, S ;
Teesch, LM ;
Morisseau, C ;
Thompson, DA ;
Hammock, BD ;
Spector, AA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14867-14874
[25]   Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries [J].
Fisslthaler, B ;
Hinsch, N ;
Chataigneau, T ;
Popp, R ;
Kiss, L ;
Busse, R ;
Fleming, I .
HYPERTENSION, 2000, 36 (02) :270-275
[26]   Cytochrome P4502C is an EDHF synthase in coronary arteries [J].
Fisslthaler, B ;
Popp, R ;
Kiss, L ;
Potente, M ;
Harder, DR ;
Fleming, I ;
Busse, R .
NATURE, 1999, 401 (6752) :493-497
[27]   The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells [J].
Fleming, I ;
Fisslthaler, B ;
Michaelis, UR ;
Kiss, L ;
Popp, R ;
Busse, R .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2001, 442 (04) :511-518
[28]   Endothelium-derived hyperpolarizing factor synthase (cytochrome P4502C9) is a functionally significant source of reactive oxygen species in coronary arteries [J].
Fleming, I ;
Michaelis, UR ;
Bredenkötter, D ;
Fisslthaler, B ;
Dehghani, F ;
Brandes, RP ;
Busse, R .
CIRCULATION RESEARCH, 2001, 88 (01) :44-51
[29]   Cytochrome P450 enzymes in vascular homeostasis [J].
Fleming, I .
CIRCULATION RESEARCH, 2001, 89 (09) :753-762
[30]   Cytochrome P4502C is an EDHF synthase in coronary arteries [J].
Fleming, I .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (04) :166-170